Penumbra Revenue 2014-2019 | PEN
Penumbra annual/quarterly revenue history and growth rate from 2014 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Penumbra revenue for the quarter ending March 31, 2019 was $0.128B, a 25.06% increase year-over-year.
- Penumbra revenue for the twelve months ending March 31, 2019 was $0.471B, a 29.57% increase year-over-year.
- Penumbra annual revenue for 2018 was $0.445B, a 33.31% increase from 2017.
- Penumbra annual revenue for 2017 was $0.334B, a 26.75% increase from 2016.
- Penumbra annual revenue for 2016 was $0.263B, a 41.5% increase from 2015.
| Penumbra Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $445 |
| 2017 | $334 |
| 2016 | $263 |
| 2015 | $186 |
| 2014 | $126 |
| 2013 | $89 |
| Penumbra Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q1 2019 | $128 |
| Q4 2018 | $121 |
| Q3 2018 | $112 |
| Q2 2018 | $110 |
| Q1 2018 | $103 |
| Q4 2017 | $96 |
| Q3 2017 | $84 |
| Q2 2017 | $81 |
| Q1 2017 | $73 |
| Q4 2016 | $73 |
| Q3 2016 | $67 |
| Q2 2016 | $65 |
| Q1 2016 | $58 |
| Q4 2015 | $54 |
| Q3 2015 | $50 |
| Q2 2015 | $42 |
| Q1 2015 | $39 |
| Q4 2014 | |
| Q3 2014 | $32 |
| Q4 2013 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.119B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $115.923B | 25.36 |
| Intuitive Surgical (ISRG) | United States | $61.050B | 53.31 |
| Edwards Lifesciences (EW) | United States | $40.518B | 40.49 |
| IDEXX Laboratories (IDXX) | United States | $24.496B | 64.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.093B | 15.17 |
| Teleflex (TFX) | United States | $15.464B | 33.51 |
| Olympus (OCPNY) | Japan | $15.120B | 113.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.591B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.533B | 39.18 |
| DexCom (DXCM) | United States | $13.892B | 272.46 |
| Hologic (HOLX) | United States | $12.939B | 20.81 |
| STERIS (STE) | Ireland | $12.366B | 29.91 |
| Varian Medical Systems (VAR) | United States | $12.078B | 30.81 |
| ABIOMED (ABMD) | United States | $11.795B | 71.75 |
| Masimo (MASI) | United States | $8.182B | 50.13 |
| SARTORIUS AG (SARTF) | Germany | $5.850B | 51.98 |
| Elekta AB (EKTAY) | Sweden | $5.087B | 38.33 |
| Integra LifeSciences Holdings (IART) | United States | $4.653B | 21.86 |
| Globus Medical (GMED) | United States | $4.220B | 26.32 |
| Tandem Diabetes Care (TNDM) | United States | $3.752B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.543B | 23.09 |
| Wright Medical Group (WMGI) | Netherlands | $3.423B | 678.50 |
| Cantel Medical (CMD) | United States | $3.306B | 33.54 |
| Glaukos (GKOS) | United States | $2.735B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.652B | 19.54 |
| Nihon Kohden (NHNKY) | Japan | $2.401B | 24.16 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.903B | 30.11 |
| Nevro (NVRO) | United States | $1.882B | 0.00 |
| Inogen (INGN) | United States | $1.287B | 28.48 |
| Silk Road Medical (SILK) | United States | $1.279B | 0.00 |
| OPKO Health (OPK) | United States | $1.274B | 0.00 |
| Veracyte (VCYT) | United States | $1.243B | 0.00 |
| CryoLife (CRY) | United States | $1.123B | 111.37 |
| Accelerate Diagnostics (AXDX) | United States | $1.017B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.009B | 148.86 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.963B | 27.90 |
| ViewRay (VRAY) | United States | $0.915B | 0.00 |
| Luminex (LMNX) | United States | $0.897B | 117.35 |
| Natus Medical (BABY) | United States | $0.893B | 20.67 |
| Mesa Laboratories (MLAB) | United States | $0.883B | 41.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.814B | 0.00 |
| Fluidigm (FLDM) | United States | $0.793B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.789B | 25.84 |
| AxoGen (AXGN) | United States | $0.756B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.692B | 0.00 |
| Intersect ENT (XENT) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.511B | 0.00 |
| Si-Bone (SIBN) | United States | $0.485B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.351B | 0.00 |
| Accuray (ARAY) | United States | $0.350B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.350B | 18.76 |
| Semler Scientific (SMLR) | United States | $0.312B | 61.99 |
| RTI Surgical (RTIX) | United States | $0.303B | 37.27 |
| SeaSpine Holdings (SPNE) | United States | $0.241B | 0.00 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.210B | 0.00 |
| ConforMIS (CFMS) | United States | $0.209B | 0.00 |
| IRadimed (IRMD) | United States | $0.204B | 38.89 |
| Sientra (SIEN) | United States | $0.172B | 0.00 |
| Stereotaxis (STXS) | United States | $0.166B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.112B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| Vermillion (VRML) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.066B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.064B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.055B | 0.00 |
